Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
Coremine Vitae offers personalized cancer treatment recommendations and follow-up, utilizing expertise in molecular biology and oncology
Innovative Solution
Coremine Vitae provides personalized treatment recommendations and follow-up for employees affected by cancer. The company leverages its expertise in molecular biology, biomedicine, oncology, and medicine to offer evidence-based reports and clinical guidelines.
Investment Funding
Revenue
$1M to $10M
People
Founders
Maria Mastrangelopoulou
About
Coremine Vitae provides personalized treatment recommendations and follow-up for employees affected by cancer. The company leverages its expertise in molecular biology, biomedicine, oncology, and medicine to offer evidence-based reports and clinical guidelines. Coremine Vitae aims to empower patients with knowledge about their treatment options, ensuring they are involved in their healthcare decisions.
Something missing or incorrect on this page? Help us enrich this information
